{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-07-30",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 13
    }
  },
  "results": [
    {
      "safetyreportversion": "1",
      "safetyreportid": "12855859",
      "primarysourcecountry": "RU",
      "occurcountry": "RU",
      "transmissiondateformat": "102",
      "transmissiondate": "20170207",
      "reporttype": "1",
      "serious": "1",
      "seriousnesshospitalization": "1",
      "seriousnessother": "1",
      "receivedateformat": "102",
      "receivedate": "20161018",
      "receiptdateformat": "102",
      "receiptdate": "20161018",
      "fulfillexpeditecriteria": "1",
      "companynumb": "RU-ASTRAZENECA-2016SF07658",
      "duplicate": "1",
      "reportduplicate": {
        "duplicatesource": "ASTRAZENECA",
        "duplicatenumb": "RU-ASTRAZENECA-2016SF07658"
      },
      "primarysource": {
        "reportercountry": "RU",
        "qualification": "5"
      },
      "sender": {
        "sendertype": "2",
        "senderorganization": "FDA-Public Use"
      },
      "receiver": {
        "receivertype": "6",
        "receiverorganization": "FDA"
      },
      "patient": {
        "patientonsetage": "62",
        "patientonsetageunit": "801",
        "patientweight": "80",
        "patientsex": "1",
        "reaction": [
          {
            "reactionmeddraversionpt": "19.1",
            "reactionmeddrapt": "Acute myocardial infarction",
            "reactionoutcome": "1"
          }
        ],
        "drug": [
          {
            "drugcharacterization": "2",
            "medicinalproduct": "DIUVER",
            "activesubstance": {
              "activesubstancename": "TORSEMIDE"
            }
          },
          {
            "drugcharacterization": "2",
            "medicinalproduct": "PLAVIX",
            "activesubstance": {
              "activesubstancename": "CLOPIDOGREL BISULFATE"
            },
            "openfda": {
              "application_number": [
                "NDA020839"
              ],
              "brand_name": [
                "PLAVIX"
              ],
              "generic_name": [
                "CLOPIDOGREL"
              ],
              "manufacturer_name": [
                "Sanofi-Aventis U.S. LLC"
              ],
              "product_ndc": [
                "0024-1171",
                "0024-1332"
              ],
              "product_type": [
                "HUMAN PRESCRIPTION DRUG"
              ],
              "route": [
                "ORAL"
              ],
              "substance_name": [
                "CLOPIDOGREL BISULFATE"
              ],
              "rxcui": [
                "213169",
                "309362",
                "749196",
                "749198"
              ],
              "spl_id": [
                "ed60a9e7-49f4-469c-bb7a-08e1bb6057e2"
              ],
              "spl_set_id": [
                "de8b0b67-eb25-4684-83b5-7ad785314227"
              ],
              "package_ndc": [
                "0024-1171-90",
                "0024-1332-30"
              ],
              "unii": [
                "08I79HTP27"
              ]
            }
          },
          {
            "drugcharacterization": "2",
            "medicinalproduct": "NOOPEPT"
          },
          {
            "drugcharacterization": "2",
            "medicinalproduct": "DIABETON"
          },
          {
            "drugcharacterization": "1",
            "medicinalproduct": "ONGLYZA",
            "drugauthorizationnumb": "022350",
            "drugstructuredosagenumb": "5",
            "drugstructuredosageunit": "003",
            "drugseparatedosagenumb": "1",
            "drugintervaldosageunitnumb": "1",
            "drugintervaldosagedefinition": "804",
            "drugcumulativedosagenumb": "5480",
            "drugcumulativedosageunit": "003",
            "drugdosageform": "TABLET",
            "drugadministrationroute": "048",
            "drugindication": "TYPE 2 DIABETES MELLITUS",
            "drugstartdateformat": "602",
            "drugstartdate": "2013",
            "actiondrug": "4",
            "activesubstance": {
              "activesubstancename": "SAXAGLIPTIN HYDROCHLORIDE"
            }
          },
          {
            "drugcharacterization": "2",
            "medicinalproduct": "DIROTON"
          },
          {
            "drugcharacterization": "2",
            "medicinalproduct": "CONCOR",
            "activesubstance": {
              "activesubstancename": "BISOPROLOL FUMARATE"
            }
          },
          {
            "drugcharacterization": "2",
            "medicinalproduct": "SIOFOR",
            "activesubstance": {
              "activesubstancename": "METFORMIN HYDROCHLORIDE"
            }
          },
          {
            "drugcharacterization": "2",
            "medicinalproduct": "VEROSPIRON",
            "activesubstance": {
              "activesubstancename": "SPIRONOLACTONE"
            }
          }
        ],
        "summary": {
          "narrativeincludeclinical": "CASE EVENT DATE: 20160910"
        }
      }
    }
  ]
}